Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A
Elke Burgermeister(Heidelberg University), Matthias Ebert(University of Mannheim)
Cited by 63
Related Papers
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer
|New England Journal of Medicine|2012|184
Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor γ
|Molecular and Cellular Biology|2006|163
Caveats of caveolin-1 in cancer progression
|Cancer Letters|2008|140